Disclosure pursuant to Regulation 14 of SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2024
Disclosure pursuant to Regulation 14 of SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2023
Disclosure pursuant to Regulation 14 of SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2022
FORM D 23022022
Disclosure pursuant to Regulation 14 of SEBI (Share Based Employee Benefits) Regulations, 2014 as on March 31, 2021
Update on ESOP
Grant of Options dated 25.03.2021
Grant of Options dated 31.03.2020
Disclosure pursuant to Regulation 14 of SEBI (Share Based Employee Benefits) Regulations, 2014 as on 31.03.2020
<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>
UPL’s acquisition of Arysta LifeScience has received regulatory approval worldwide and together we are moving fast to creating a new leader in global agriculture.
Our websites will continue to be the best place to get news updates over the next months as we fully integrate our combined businesses.
Thank You.
